RFG Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.66M | Sell |
20,666
-5,172
| -20% | -$605K | 0.04% | 305 |
|
|
2026
Q1 | $3.11M | Sell |
25,838
-21,956
| -46% | -$2.53M | 0.06% | 254 |
|
|
2025
Q4 | $5.03M | Buy |
47,794
+79
| +0.2% | +$7.42K | 0.09% | 161 |
|
|
2025
Q3 | $4M | Sell |
47,715
-387
| -0.8% | -$31.9K | 0.08% | 176 |
|
|
2025
Q2 | $3.81M | Sell |
48,102
-15,467
| -24% | -$1.23M | 0.09% | 176 |
|
|
2025
Q1 | $5.71M | Buy |
63,569
+30,274
| +91% | +$2.83M | 0.15% | 96 |
|
|
2024
Q4 | $3.31M | Sell |
33,295
-9,195
| -22% | -$948K | 0.09% | 168 |
|
|
2024
Q3 | $4.83M | Sell |
42,490
-6,225
| -13% | -$740K | 0.15% | 121 |
|
|
2024
Q2 | $6.03M | Buy |
48,715
+10,746
| +28% | +$1.38M | 0.2% | 87 |
|
|
2024
Q1 | $5.01M | Sell |
37,969
-1,039
| -3% | -$128K | 0.17% | 103 |
|
|
2023
Q4 | $4.25M | Sell |
39,008
-1,467
| -4% | -$152K | 0.17% | 104 |
|
|
2023
Q3 | $4.17M | Buy |
40,475
+5,360
| +15% | +$578K | 0.19% | 94 |
|
|
2023
Q2 | $4.05M | Sell |
35,115
-1,242
| -3% | -$141K | 0.18% | 93 |
|
|
2023
Q1 | $3.87M | Sell |
36,357
-520
| -1% | -$56.1K | 0.19% | 102 |
|
|
2022
Q4 | $3.8M | Sell |
36,877
-384
| -1% | -$39.3K | 0.19% | 97 |
|
|
2022
Q3 | $3.78M | Buy |
37,261
+3,169
| +9% | +$283K | 0.22% | 93 |
|
|
2022
Q2 | $2.98M | Buy |
34,092
+13,181
| +63% | +$1.17M | 0.17% | 101 |
|
|
2022
Q1 | $1.72M | Sell |
20,911
-40
| -0.2% | -$3.15K | 0.11% | 129 |
|
|
2021
Q4 | $1.61M | Buy |
20,951
+547
| +3% | +$43.6K | 0.11% | 135 |
|
|
2021
Q3 | $1.53M | Buy |
20,404
+6,129
| +43% | +$466K | 0.13% | 119 |
|
|
2021
Q2 | $1.11M | Sell |
14,275
-1,495
| -9% | -$111K | 0.1% | 155 |
|
|
2021
Q1 | $1.16M | Sell |
15,770
-328
| -2% | -$24.2K | 0.13% | 135 |
|
|
2020
Q4 | $1.27M | Sell |
16,098
-1,693
| -10% | -$129K | 0.17% | 118 |
|
|
2020
Q3 | $1.41M | Buy |
17,791
+100
| +0.6% | +$7.83K | 0.2% | 100 |
|
|
2020
Q2 | $1.3M | Buy |
17,691
+1,725
| +11% | +$130K | 0.2% | 94 |
|
|
2020
Q1 | $1.17M | Buy |
15,966
+1,137
| +8% | +$89.4K | 0.22% | 95 |
|
|
2019
Q4 | $1.29M | Buy |
14,829
+2,662
| +22% | +$219K | 0.22% | 91 |
|
|
2019
Q3 | $977K | Buy |
12,167
+589
| +5% | +$47.2K | 0.19% | 94 |
|
|
2019
Q2 | $927K | Buy |
11,578
+5,450
| +89% | +$417K | 0.21% | 94 |
|
|
2019
Q1 | $487K | Buy |
6,128
+206
| +3% | +$15.4K | 0.12% | 143 |
|
|
2018
Q4 | $432K | Sell |
5,922
-1,505
| -20% | -$106K | 0.11% | 149 |
|
|
2018
Q3 | $560K | Buy |
7,427
+1,471
| +25% | +$93.7K | 0.15% | 139 |
|
|
2018
Q2 | $345K | Sell |
5,956
-8,901
| -60% | -$502K | 0.1% | 154 |
|
|
2018
Q1 | $772K | Sell |
14,857
-446
| -3% | -$24.1K | 0.29% | 61 |
|
|
2017
Q4 | $827K | Buy |
15,303
+1,279
| +9% | +$70.9K | 0.39% | 62 |
|
|
2017
Q3 | $861K | Sell |
14,024
-407
| -3% | -$24.7K | 0.53% | 36 |
|
|
2017
Q2 | $866K | Sell |
14,431
-305
| -2% | -$18.6K | 0.6% | 29 |
|
|
2017
Q1 | $894K | Buy |
14,736
+6,147
| +72% | +$373K | 0.68% | 33 |
|
|
2016
Q4 | $512K | Hold |
8,589
| – | – | 0.49% | 38 |
|
|
2016
Q3 | $512K | Buy |
8,589
+21
| +0.2% | +$1.23K | 0.47% | 39 |
|
|
2016
Q2 | $471K | Sell |
8,568
-21
| -0.2% | -$1.12K | 0.41% | 47 |
|
|
2016
Q1 | $434K | Buy |
8,589
+2,012
| +31% | +$98.5K | 0.34% | 53 |
|
|
2015
Q4 | $331K | Buy |
6,577
+412
| +7% | +$20.8K | 0.24% | 37 |
|
|
2015
Q3 | $291K | Sell |
6,165
-1,099
| -15% | -$58.4K | 0.94% | 37 |
|
|
2015
Q2 | $395K | Buy |
+7,264
| New | +$407K | 0.18% | 89 |
|
Other funds holding MRK
LMFP
ATO
QP
RFG Advisory's MRK Position: Q2 2026 in Review
RFG Advisory reduced its Merck (MRK) stake by 20% in Q2 2026, selling an estimated $605K and leaving 20,666 shares worth $2.66M. The position accounts for 0.04% of the portfolio, ranked #305.
RFG Advisory first reported a position in MRK in Q2 2015 and has held it in 45 quarters since. The position peaked at $6.03M in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- RFG Advisory held 20,666 shares of Merck worth $2.66M as of Q2 2026.
- RFG Advisory sold 5,172 Merck shares in Q2 2026, an estimated $605K.
- Merck made up 0.04% of RFG Advisory's portfolio in Q2 2026, its #305 holding.
- RFG Advisory first reported a position in Merck in Q2 2015 and has held it in 45 quarters since.
- RFG Advisory's Merck position peaked at $6.03M in Q2 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.